Financial Daily from THE HINDU group of publications
Thursday, Oct 07, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Outlook


Ind-Swift Labs in talks with 2 cos for making statins

P.T. Jyothi Datta

Mumbai , Oct. 6

IND-SWIFT Laboratories Ltd (ISLL), a Chandigarh-based bulk drugs company, is in talks with two generic pharmaceutical companies for the manufacture of statins (cholesterol-lowering agents).

The company expects to finalise this contract manufacturing deal by end-November, company officials told Business Line.

The development is in the backdrop of a massive capacity increase that ISLL has undertaken to meet the surge in global demand for statins.

Statins account for $22 billion of the $60-billion cardiovascular market, according to industry sources. Ind-Swift expects to corner revenues to the tune of Rs 150 crore by March 2006 through its contract manufacturing initiatives for statins, an ISLL official said.

To tap the global opportunity in contract manufacturing for statins, the company will be scaling up its capacity by about 500 per cent by 2005.

The company's current statin production capacity is 7.5 tonnes per annum and this is being scaled up to 40 tonnes per annum through the setting up of a new plant.

ISLL has commercially launched its synthetic statins - Rosuvastatin and Ezetimibe, molecules with an expected market size of $8 billion, the company official said.

Only recently ISLL had inked contract research agreements with two European companies worth $3-5 million for molecules with a market size of over $8 billion, which are to be completed in 18 months.

Ind-Swift Labs expects contract research and manufacturing agreements to contribute to about 45 per cent of its bottom line in the next 2-3 years. It has invested about Rs 4.5 crore during the year in research-related activities.

More Stories on : Outlook | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Toyota launches new Camry; latest Corolla to follow suit


BHEL bags Oman order
KMML in pact for LNG supply
Tender dispute stalls BSNL's rural telephony project
Birla will executor seeks discharge of caveat filed by Lodha
No concept, only paper
E&Y ex-partners form audit firm
RBI asks `problem' cos not to repay deposits before term
AS Steel Traders highest bidder for Orichem
Guidelines on valuation of corporate assets to be framed
Maruti top brass in Japan to work out Rs 6,000-cr investment
Piaggio plans expansion of manufacturing base
Welspun to get $15 m from IFC for plant expansion
Apollo Tyres completes expansion
Ranbaxy setting up plant in Brazil
FICCI urges PM for continuation of Press Note 18
GV Films collaboration
Defluorination plant opened in Warangal dist
Mafatlal still struggling to get out of the woods — Polyolefins rights issue to pay debts
LG India targets $3-b export turnover by 2010
Ind-Swift Labs in talks with 2 cos for making statins
Adecco Peopleone targets Rs 160-cr revenue by March '06
GM sales rise 60 pc in Sept
Tata Motors sales up 25% in Sept
Temasek's Lee on Apollo Hospitals board



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line